Mayumi Ueyama

Antiviral effects of the interferon‐induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein†

Yasuhiro Itsui, Naoya Sakamoto, Sei Kakinuma et al. · Hepatology · 2009 · 164 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice

Izumi Onozuka, Sei Kakinuma, Akihide Kamiya et al. · Biochemical and Biophysical Research Communications · 2011 · 59 citations

Medicine, Pathobiology, Pathology +15

Analysis of Interferon Signaling by Infectious Hepatitis C Virus Clones with Substitutions of Core Amino Acids 70 and 91

Yusuke Funaoka, Naoya Sakamoto, Goki Suda et al. · Journal of Virology · 2011 · 51 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Association of IL28B variants with response to pegylated‐interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b

Naoya Sakamoto, Mina Nakagawa, Yasuhito Tanaka et al. · Journal of Medical Virology · 2011 · 47 citations

Life Sciences, Immunology, Pharmacology +17

Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells

Yuki Nishimura‐Sakurai, Naoya Sakamoto, Kaoru Mogushi et al. · Journal of Gastroenterology · 2009 · 30 citations

Life Sciences, Infectious Diseases, Molecular Biology +14